Bruce M. Camitta , MD                   

Bruce Camitta, MDTitles
Rebecca Jean Slye Chair in Oncology, Children's Hospital of Wisconsin; professor, Pediatrics (Oncology), Medical College of Wisconsin.

Division
Hematology, Oncology and Transplant

Research interests
Cancer

Study interests
Acute leukemias of childhood, aplastic anemia, blood and marrow transplantation.

Education
Medical degree, Johns Hopkins, Baltimore, 1966; residency: Children's Hospital of Pittsburgh, 1966-1968 and Johns Hopkins, 1968-1969; fellowship, Harvard University, Boston Children's Hospital, 1971-74.

Certifications
Pediatrics, Pediatric Hematology-Oncology.  

Representative publications

  • Camitta BM, Storb R, Thomas ED. Aplastic Anemia: Pathogenesis, Diagnosis, Treatment and Prognosis. New England Journal of Medicine. 1982; 306:645-712. 
  • Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn E, Link M, Murphy S, Pui C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Ucken F, Ungerleider R. A Uniform Approach to Risk-classification and Treatment Assignment for Children with Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 1996; 14:18.
  • Mahoney DH, Shuster J, Nitschke R, Lauer S, Winick N, Camitta B. Intermediate Dose Methotrexate with Intravenous Mercaptopurine is Superior to Repetitive Low Dose Oral Methotrexate with Intravenous Mercaptopurine for Children with Lower Risk B-lineage Acute Lymphoblastic Leukemias: A Pediatric Oncology Group Phase III Trial. Journal of Clinical Oncology. 1998; 16:246.
  • Arico M, Valsecehi MG, Camitta BM, Schrappe M, Chessells J, Baruchel A, Gaynon P, Sallan S, Janka-Schaub G, Kamps W, Pui C-H, Masera G. Heterogeneity of Treatment Outcome in Children with Philadelphia Chromosome: Positive Acute Lymphoblastic Leukemia. New England Journal of Medicine. 2000; 342:998.
  • Lauer SJ, Shuster JJ, Mahoney DH, Winick N, Toledano S, Munoz L, Kiefer G, Pullen J, Steuber CP, Camitta BM. A Comparison of Early Intensive Methotrexate/Mercaptopurine with Early Intensive Alternating Combination Chemotherapy for High-risk B-precursor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Phase III Randomized Trial. Leukemia. 2001; 15:1038.
  • Pui C-H, Gaynon PS, Boyette JM, Chessels JM, Baruchel A, Kamps W, Silverman LB, Biondi A, Harms DO, Vilmer E, Schrappe M, Camitta B. Outcome of Treatment in Childhood Acute Lymphoblastic Leukaemia with Rearrangements of the 11q23 Chromosomal Region. Lancet. 2002; 359:1909.

Grants

  • Midwest Athletes Against Childhood Cancer, general support.

Contact
Children's Research Institute
8701 Watertown Plank Road
Wauwatosa, WI 53226
Phone: (414) 456-4106
Fax: (414) 456-6543
E-mail: bcamitta@mcw.edu

Investigator in areas of: